Impact of deleterious passenger mutations on cancer progression

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 8, 2013, Pages 2910-2915

  McFarland, Christopher D ^a   Korolev, Kirill S ^b   Kryukov, Gregory V ^c,d   Sunyaev, Shamil R ^a,c,d   Mirny, Leonid A ^a,b,c,e  

^a HARVARD UNIVERSITY   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

Chaperones; Population genetics; Stochastic simulations; Unfolding response pathway

Indexed keywords

ARTICLE; CANCER GROWTH; CANCER MODEL; CANCER REGRESSION; CANCER THERAPY; DISEASE SIMULATION; DORMANCY; GENE MUTATION; MUTATION RATE; NATURAL SELECTION; PRIORITY JOURNAL; SOMATIC MUTATION;

DISEASE PROGRESSION; EVOLUTION, MOLECULAR; HUMANS; MODELS, BIOLOGICAL; MUTATION; NEOPLASMS;

EID: 84874231197     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1213968110     Document Type: Article

References (53)

1. Pleasance ED, et al. (2010) A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463 (7278):191-196.
2. Pleasance ED, et al. (2010) A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 463 (7278):184-190.
3. Beroukhim R, et al. (2010) The landscape of somatic copy-number alteration across human cancers. Nature 463 (7283):899-905.
4. Sjöblom T, et al. (2006) The consensus coding sequences of human breast and co-lorectal cancers. Science 314 (5797):268-274.
5. Sharma S, Kelly TK, Jones PA (2010) Epigenetics in cancer. Carcinogenesis 31 (1):27-36.
6. Maley CC, et al. (2004) Selectively advantageous mutations and hitchhikers in neoplasms: p16 lesions are selected in Barrett's esophagus. Cancer Res 64 (10):3414-3427.
7. Haeno H, Iwasa Y, Michor F (2007) The evolution of two mutations during clonal expansion. Genetics 177 (4):2209-2221.
8. Futreal PA, et al. (2004) A census of human cancer genes. Nat Rev Cancer 4 (3):177-183.
9. Chapman MA, et al. (2011) Initial genome sequencing and analysis of multiple myeloma. Nature 471 (7339):467-472.
10. Moran NA (1996) Accelerated evolution and Muller's ratchet in endosymbiotic bacteria. Proc Natl Acad Sci USA 93 (7):2873-2878.
11. Walczak AM, Nicolaisen LE, Plotkin JB, Desai MM (2012) The structure of genealogies in the presence of purifying selection: A fitness-class coalescent. Genetics 190 (2):753-779.
12. Lynch M, Bürger R, Butcher D, Gabriel W (1993) The mutational meltdown in asexual populations. J Hered 84 (5):339-344.
13. Neznanov N, Komarov AP, Neznanova L, Stanhope-Baker P, Gudkov AV (2011) Pro-teotoxic stress targeted therapy (PSTT): Induction of protein misfolding enhances the antitumor effect of the proteasome inhibitor bortezomib. Oncotarget 2 (3):209-221.
14. Geiler-Samerotte KA, et al. (2011) Misfolded proteins impose a dosage-dependent fitness cost and trigger a cytosolic unfolded protein response in yeast. Proc Natl Acad Sci USA 108 (2):680-685.
15. Boyko AR, et al. (2008) Assessing the evolutionary impact of amino acid mutations in the human genome. PLoS Genet 4 (5):e1000083.
16. Andersen MH, Schrama D, Thor Straten P, Becker JC (2006) Cytotoxic T cells. J Invest Dermatol 126 (1):32-41.
17. Gillespie JH (2004) Population Genetics: A Concise Guide (Johns Hopkins Univ Press, Baltimore).
18. Spencer SL, Gerety RA, Pienta KJ, Forrest S (2006) Modeling somatic evolution in tumorigenesis. PLOS Comput Biol 2 (8):e108.
19. Beerenwinkel N, et al. (2007) Genetic progression and the waiting time to cancer. PLOS Comput Biol 3 (11):e225.
20. Iwasa Y, Nowak MA, Michor F (2006) Evolution of resistance during clonal expansion. Genetics 172 (4):2557-2566.
21. Laird AK (1964) Dynamics of tumor growth. Br J Cancer 13:490-502.
22. Bozic I, et al. (2010) Accumulation of driver and passenger mutations during tumor progression. Proc Natl Acad Sci USA 107 (43):18545-18550.
23. Kim S, Chin K, Gray JW, Bishop JM (2004) A screen for genes that suppress loss of contact inhibition: Identification of ING4 as a candidate tumor suppressor gene in human cancer. Proc Natl Acad Sci USA 101 (46):16251-16256.
24. Johnston MD, Edwards CM, Bodmer WF, Maini PK, Chapman SJ (2007) Mathematical modeling of cell population dynamics in the colonic crypt and in colorectal cancer. Proc Natl Acad Sci USA 104 (10):4008-4013.
25. Felsenstein J (1974) The evolutionary advantage of recombination. Genetics 78 (2):737-756.
26. Guthrie J (1966) Effects of a synthetic antigonadotrophin (2-amino, 5-nitrothiazole) on growth of experimental testicular teratomas. Br J Cancer 20 (3):582-587.
27. Gibson MA, Bruck J (2000) Efficient exact stochastic simulation of chemical systems with many species and many channels. J Phys Chem A 104 (9):1876-1889.
28. Loeb LA, Bielas JH, Beckman RA (2008) Cancers exhibit a mutator phenotype: Clinical implications. Cancer Res 68 (10):3551-3557, discussion 3557.
29. Cole AM, et al. (2010) Cyclin D2-cyclin-dependent kinase 4/6 is required for efficient proliferation and tumorigenesis following Apc loss. Cancer Res 70 (20):8149-8158.
30. Forbes SA, et al. (2008) The Catalogue of Somatic Mutations in Cancer (COSMIC). Curr Protoc Hum Genet Chapter 10:Unit 10.11.
31. Beckman RA, Loeb LA (2005) Negative clonal selection in tumor evolution. Genetics 171 (4):2123-2131.
32. Berger MF, et al. (2012) Melanoma genome sequencing reveals frequent PREX2 mutations. Nature 485 (7399):502-506.
33. Fischer A, Greenman C, Mustonen V (2011) Germline fitness-based scoring of cancer mutations. Genetics 188 (2):383-393.
34. Gupta PB, et al. (2011) Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 146 (4):633-644.
35. Korolev KS, et al. (2012) Selective sweeps in growing microbial colonies. Phys Biol 9 (2): 026008.
36. Korolev KS, Avlund M, Hallatschek O, Nelson DR (2010) Genetic demixing and evolution in linear stepping stone models. Rev Mod Phys 82 (2):1691-1718.
37. Aguirre-Ghiso JA (2006) The problem of cancer dormancy: Understanding the basic mechanisms and identifying therapeutic opportunities. Cell Cycle 5 (16):1740-1743.
38. Brunet E, Rouzine IM, Wilke CO (2008) The stochastic edge in adaptive evolution. Genetics 179 (1):603-620.
39. Gordo I, Charlesworth B (2000) On the speed of Muller's ratchet. Genetics 156 (4):2137-2140.
40. Neher RA, Shraiman BI (2012) Fluctuations of fitness distributions and the rate of Muller's ratchet. Genetics 191 (4):1283-1293.
41. Haigh J (1978) The accumulation of deleterious genes in a population-Muller's ratchet. Theor Popul Biol 14 (2):251-267.
42. Sunyaev SR, et al. (1999) PSIC: Profile extraction from sequence alignments with position-specific counts of independent observations. Protein Eng 12 (5):387-394.
43. Birkbak NJ, et al. (2011) Paradoxical relationship between chromosomal instability and survival outcome in cancer. Cancer Res 71 (10):3447-3452.
44. Fudenberg G, Getz G, Meyerson M, Mirny LA (2011) High order chromatin architecture shapes the landscape of chromosomal alterations in cancer. Nat Biotechnol 29 (12):1109-1113.
45. Sheltzer JM, et al. (2011) Aneuploidy drives genomic instability in yeast. Science 333 (6045):1026-1030.
46. Dai C, Whitesell L, Rogers AB, Lindquist S (2007) Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis. Cell 130 (6):1005-1018.
47. De Raedt T, et al. (2011) Exploiting cancer cell vulnerabilities to develop a combination therapy for ras-driven tumors. Cancer Cell 20 (3):400-413.
48. Wust P, et al. (2002) Hyperthermia in combined treatment of cancer. Lancet Oncol 3 (8):487-497.
49. Soong NW, Hinton DR, Cortopassi G, Arnheim N (1992) Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain. Nat Genet 2 (4):318-323.
50. Santagata S, et al. (2011) High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer. Proc Natl Acad Sci USA 108 (45):18378-18383.
51. Silva JM, et al. (2000) DNA damage after chemotherapy correlates with tumor response and survival in small cell lung cancer patients. Mutat Res 456 (1-2):65-71.
52. Parsons DW, et al. (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807-1812.
53. Ley TJ, et al. (2008) DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 456:66-72.